BUYINS.NET: Market Maker Surveillance Report. ICAD, AMRI, CACH, OKOFF, PBSV, RPXC, Winning Stocks With Lowest Price Friction For Wednesday, February 13th 2013
(M2 PressWIRE Via Acquire Media NewsEdge) BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3926 companies with "abnormal" market making, 2845 companies with positive Friction Factors and 2433 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. iCAD Inc (NASDAQ:ICAD), Albany Molecular Research Inc (NASDAQ:AMRI), Cache Inc (NASDAQ:CACH), ORKO SILVER CORP (OTC:OKOFF), PHARMA-BIO SERV INC (OTC:PBSV), RPX CORP (NASDAQ:RPXC). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
Market Maker Friction Factor is shown in the chart below:
Symbol Change Percent Buy Volume Buy %% Sell Volume Sell %% Net Volume Friction
ICAD $0.880 17.22% 195,902 55.85% 154,463 44.04% 41,439 471
AMRI $0.840 12.82% 594,788 54.82% 490,224 45.18% 104,564 1,245
CACH $0.510 12.29% 97,650 51.05% 92,340 48.27% 5,310 104
OKOFF $0.446 20.89% 244,625 49.56% 203,237 41.18% 41,388 928
PBSV $0.130 11.61% 33,650 42.98% 32,600 41.63% 1,050 81
RPXC $2.360 22.08% 554,358 50.08% 543,886 49.13% 10,472 44
Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.
For example, the chart above shows ICAD with a dollar gain Wednesday of $0.88000 and a Friction Factor of 471 shares. That means that it only took 471 more shares of buying than selling to move ICAD higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.
iCAD Inc (NASDAQ:ICAD) - iCAD, Inc. provides image analysis and workflow solutions that enable radiologists and other healthcare professionals to identify pathologies and pinpoint cancer earlier. It offers CAD solutions for digital and film-based mammography systems, including SecondLook systems, which analyze data, and automatically identify and mark suspicious regions in the images; and SecondLook Digital, a computer server residing on a customer s network that receives patient studies from the imaging modality, performs CAD analysis, and sends the CAD results to PACS and/or review workstations. The company also offers image analysis and workflow solutions in MRI imaging, including SpectraLook for breast, VividLook for prostate, and OmniLook for other organs; and VersaVue Enterprise, a review and reporting solution that provides visual and quantitative depictions of the movement of contrast agent through a lesion. In addition, it offers VeraLook, which supports the detection of colonic polyps in conjunction with CT colonography; The TotalLook MammoAdvantage system, a mammography specific digitizer; and Axxent eBx, which is used for the treatment of early stage breast cancer, endometrial cancer, and skin cancer, as well as for the treatment of other cancers or conditions where radiation therapy is indicated. The company sells its products to hospitals, ambulatory care centers, and free standing radiation oncology facilities. It sells its products directly, as well as through various original equipment manufacturer partners, distributors, and resellers worldwide. The company was founded in 1984 and is headquartered in Nashua, New Hampshire..
Albany Molecular Research Inc (NASDAQ:AMRI) - Albany Molecular Research, Inc. provides various drug discovery, development, and manufacturing services in the United States, Europe, and Asia. The company offers a range of drug discovery services, including assay development and design, screening, screening library, natural product, medicinal chemistry, computer-aided drug discovery, in vitro ADMET, and bioanalytical services. It also provides chemical development services comprising process research and development, custom synthesis, process safety assessment, scale-up capabilities, high potency and controlled substances, analytical services, preformulation services and physical characterization, preparative chromatography, IND support services, fermentation development and optimization, and building blocks collection and database services; and chemical synthesis and manufacturing services. In addition, the company offers contract manufacturing services in sterile syringe and vial filling for small molecule drug products and biologicals; and formulation services, such as aseptic fill and finish, aseptic lyophilization, neat active pharmaceutical ingredients or pharmaceutical blend in capsules, powder in bottle for solution and suspension, blending and sieving, milling, tableting, rheology, roller compaction, wet granulation, and fluid bed processing, as well as associated analytical testing services for dosage formulation products. Further, it provides various analytical chemistry services consisting of impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; analytical and preparative supercritical fluid chromatography; preparative chromatography; laboratory practices bioanalytical services; and regulatory support/quality assurance services. It serves pharmaceutical and biotechnology companies. The company was founded in 1991 and is based in Albany, New York..
Cache Inc (NASDAQ:CACH) - Cache, Inc., together with its subsidiaries, operates as a mall and Web based specialty retailer of women s lifestyle sportswear and dresses in the United States. It offers eveningwear; casual and daytime sportswear, including tops, bottoms, and dresses; and accessories, such as jewelry, belts, and handbags under the Cache brand name. The company also provides its products online through its Web site, cache.com. As of August 14, 2012, it operated 263 stores in 42 states, Puerto Rico, and the U.S. Virgin Islands. The company was founded in 1975 and is headquartered in New York, New York..
ORKO SILVER CORP (OTC:OKOFF) - Orko Silver Corp., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties in Mexico. It primarily explores for silver and gold. The company holds a 100% interest in the La Preciosa silver project comprising La Preciosa, Santa Monica, and San Juan properties covering an area of 80,000 acres of contiguous mining claims located in Durango, Mexico. Orko Silver Corp. was incorporated in 1983 and is based in Vancouver, Canada..
PHARMA-BIO SERV INC (OTC:PBSV) - Pharma-Bio Serv, Inc. provides technical compliance consulting service, and microbiological and chemical laboratory testing services primarily to the pharmaceutical, chemical, medical device, and biotechnology industries in Puerto Rico, the United States, and Ireland. The company s technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management, and process support. It also provides information technology services, such as Web pages and portals development, digital art design, intranets, extranets, software development that includes database integration, Windows and Web applications development, software technical training and learning management systems, technology project management, and compliance consulting services. In addition, the company offers microbiological testing services and chemical testing services; and technical trainings/seminars. It markets its services through industry trade shows, professional conventions, industry publications, and company provided seminars. The company was formerly known as Lawrence Consulting Group, Inc. and changed its name to Pharma-Bio Serv, Inc. in February 2006. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico..
RPX CORP (NASDAQ:RPXC) - .
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to firstname.lastname@example.org)).
(c) 2013 M2 COMMUNICATIONS
[ Back To IBM News 's Homepage ]